Vice President of Product Development @ (May 2016 - June 2020)
Senior Director, CMC and Operations @ Mallinckrodt Pharmaceuticals (formerly Questcor Pharmaceuticals via merger Augus (August 2011 - May 2016)
Acting Vice President, Product Development and Operations @ Cerecor Inc (May 2010 - July 2013)
Co-Founder @ Fells Laboratories LLC (November 2010 - May 2011)
Sr. Director of CMC @ ALBA Therapeutics (March 2006 - August 2010)
Associate Director of Preformulation Sciences @ Shire Pharmaceuticals (March 2002 - January 2006)
Sr Scientist @ Guilford Pharmaceuticals (January 1998 - January 2002)
Mark Ginski Education
University of Maryland
Ph.D. (Pharmaceutical Sciences)
1994-1998
University of Maryland Baltimore County
B.S. (Biological Sciences)
1989-1994
Mark Ginski Skills
Analytical Chemistry
Clinical Trials
Biotechnology
Technology Transfer
Drug Development
Formulation
HPLC
Vaccines
R&D
Lifesciences
Clinical Development
Drug Discovery
Life Sciences
Science
Laboratory
Biopharmaceuticals
Pharmaceutical Industry
Public Speaking
CMC
Entrepreneurship
Customer Service
Leadership
Microsoft Office
Business Development
Strategic Planning
Operations
Mark Ginski Summary
Mark Ginski, based in Kingsville, MD, US, is currently a Senior Vice President, CMC at VistaGen Therapeutics, Inc.. Mark Ginski brings experience from previous roles at CMC Consultants LLC, ANI Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals (formerly Questcor Pharmaceuticals via merger Augus and Cerecor Inc. Mark Ginski holds a 1994 - 1998 Ph.D. in Pharmaceutical Sciences @ University of Maryland. With a robust skill set that includes Analytical Chemistry, Clinical Trials, Biotechnology, Technology Transfer, Drug Development and more. Mark Ginski has 6 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Ginski?
Find contact details for 700 million professionals.